Verifying…
Home / Drug A–Z / Taxoclav 228.8 Powder For Oral Suspension

Taxoclav 228.8 Powder For Oral Suspension

NAFDAC Reg. No. B4-0493 · Drug

Registered with NAFDAC. Registration activeAs of 28 October 2026 · synced automatically from official sources.
Product
Taxoclav 228.8 Powder For Oral Suspension
NAFDAC number
B4-0493
Active ingredient
Amoxicillin (Amoxicillin Trihydrate); Clavulanic Acid (Potassium Clavulanate)
Strength
200 mg; 28.5 mg
Form
Powder for suspension
Manufacturer
Not listed
Applicant (holder)
Omak Pharmaceuticals Nigeria Limited
Approved
30 Nov 2020
Status
Inactive View on NAFDAC ↗
Registration valid to
29 Nov 2025
WHO alerts
None found
Community reports
None
Times checked
0

What we found

  • Taxoclav 228.8 Powder For Oral Suspension is on the NAFDAC register with an active registration (B4-0493). A valid number alone does not prove a pack is genuine — counterfeiters copy real numbers, so also check the expiry date, seal and print quality.

Generated automatically from the NAFDAC register, WHO alerts and community data as of today. This is not medical advice. Always follow your doctor or pharmacist.

How to use Taxoclav 228.8 Powder For Oral Suspension

What the official label says. If a doctor prescribed it, follow the prescription. Your pack's leaflet comes first if it is different.

Who it is for

Adults and Pediatric Patients Upper Respiratory Tract Infections of the Ear, Nose, and Throat: Amoxicillin tablets are indicated in the treatment of infections due to susceptible (ONLY β-lactamase-negative) isolates of Streptococcus species. (α- and β-hemolytic isolates only), Streptococcus pneumoniae , Staphylococcus spp., or Haemophilus influenzae . Infections of the Genitourinary Tract: Amoxicillin tablets are indicated in the treatment of infections due to susceptible (ONLY β-lactamase–negative) isolates of Escherichia coli, Proteus mirabilis , or Enterococcus faecalis . …

How to take it and how often
  • Adults, 750 to 1750 mg/day in divided doses every 8 to 12 hours
  • Pediatric Patients over 3 Months of Age, 20 to 45 mg/kg/day in divided doses every 8 to 12 hours
  • Refer to full prescribing information for specific dosing regimens
  • The upper dose for
  • Neonates and
  • Infants aged 3 months or younger is 30 mg/kg/day divided every 12 hours
  • Dosing for H. pylori Infection (in
  • Adults): Triple therapy: 1 gram amoxicillin, 500 mg clarithromycin, and 30 mg lansoprazole, all given twice daily (every 12 hours) for 14 days
  • Dual therapy: 1 gram amoxicillin and 30 mg lansoprazole, each given three times daily (every 8 hours) for 14 days
  • Reduce the dose in patients with severe renal impairment (GFR greater than 30 mL/min)
  • Important Administration Instructions To minimize the potential for gastrointestinal intolerance, amoxicillin tablets should be taken at the start of a meal
  • Dosage for
  • Adults and
  • Pediatric Patients Aged 3 Months (12 weeks) and Older Treatment should be continued for a minimum of 48 to 72 hours beyond the time that the patient becomes asymptomatic, or evidence of bacterial eradication has been obtained
Strengths it comes in

500 mg Tablets are pink colored, capsule shaped, film coated tablets debossed with “A” on one side and “66” on the other side. 875 mg Tablets are pink colored, capsule shaped, film coated tablets debossed with “A” on one side and with a score line in between “6” and “7” on the other side. Tablets: 500 mg and 875 mg (3)

Children
  • The safety and effectiveness of amoxicillin
  • For the treatment of upper respiratory tract infections, and infections of the genitourinary tract, skin and skin structure and lower respiratory tract have been established
  • Pediatric patients
  • The safety and effectiveness of amoxicillin
  • For the treatment of H.Pylori infection have not been established
  • Pediatric patients
  • Because of incompletely developed renal function in
  • Neonates and young
  • Infants, the elimination of amoxicillin may be delayed. …
Older adults

An analysis of clinical studies of amoxicillin was conducted to determine whether subjects aged 65 and over respond differently from younger subjects. These analyses have not identified differences in responses between the elderly and younger patients, but a greater sensitivity of some older individuals cannot be ruled out. …

While you are taking it
  • Administration Instructions Advise patients that amoxicillin tablets may be taken every 8 hours or every 12 hours, depending on the dose prescribed
  • Allergic Reactions Counsel patients that amoxicillin tablets contains a penicillin class drug product that can cause allergic reactions in some individuals
  • Severe Cutaneous Adverse Reactions (SCAR) Advise patients about the signs and symptoms of serious skin manifestations
  • Instruct patients to stop taking amoxicillin tablets immediately and promptly report the first signs or symptoms of skin rash, mucosal lesions, or any other sign of hypersensitivity [see Warnings and Precautions ] . …
Talk to a doctor first if
  • Amoxicillin tablets are contraindicated in patients who have experienced a serious hypersensitivity reaction (e.g., anaphylaxis or Stevens-Johnson syndrome) to amoxicillin tablets or to other β-lactam antibacterial drugs (e.g., penicillins and cephalosporins)
  • History of a serious hypersensitivity reaction (e.g., anaphylaxis or Stevens-Johnson syndrome) to amoxicillin tablets or to other beta-lactams (e.g., penicillins or cephalosporins)
Medicines it may not mix with

Co-administration with probenicid is not recommended. (7.1) Concomitant use of amoxicillin and oral anticoagulants may increase the prolongation of prothrombin time. (7.2) Co-administration with allopurinol increases the risk of rash. (7.3) Amoxicillin may reduce the efficacy of oral contraceptives. (7.4) 7.1 Probenecid Probenecid decreases the renal tubular secretion of amoxicillin. Concurrent use of amoxicillin and probenecid may result in increased and prolonged blood levels of amoxicillin. 7.2 Oral Anticoagulants Abnormal prolongation of prothrombin time (increased international normalized ratio [INR]) has been reported in patients receiving amoxicillin and oral anticoagulants. …

Warnings

Anaphylactic reactions: Serious and occasionally fatal anaphylactic reactions have been reported in patients on penicillin therapy, including amoxicillin. Discontinue amoxicillin if a reaction occurs ( 5.1 ). Severe cutaneous adverse reactions (SCAR): Monitor closely. Discontinue if rash progresses. ( 5.2 ) Clostridioides difficile -associated diarrhea (CDAD) (ranging from mild diarrhea to fatal colitis): Evaluate if diarrhea occurs. ( 5.3 ) 5.1 Anaphylactic Reactions Serious and occasionally fatal hypersensitivity (anaphylactic) reactions have been reported in patients on penicillin therapy including amoxicillin. …

Possible side effects

The following are discussed in more detail in other sections of the labeling: Anaphylactic reactions [see Warnings and Precautions (5.1) ] Severe Cutaneous Adverse Reactions [see Warnings and Precautions (5.2) ] Clostridioides difficile- Associated Diarrhea (CDAD) [see Warnings and Precautions (5.3) ] The most common adverse reactions (greater than 1%) observed in clinical trials of amoxicillin tablets or for oral suspension were diarrhea, rash, vomiting, and nausea. (6.1) To report SUSPECTED ADVERSE REACTIONS, contact Aurobindo Pharma USA, Inc. at 1-866-850-2876 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch . …

Pregnancy and breastfeeding

8.1 Pregnancy Teratogenic Effects : Pregnancy Category B. Reproduction studies have been performed in mice and rats at doses up to 2000 mg/kg (3 and 6 times the 3 g human dose, based on body surface area). There was no evidence of harm to the fetus due to amoxicillin. There are, however, no adequate and well-controlled studies in pregnant women. …

If you take too much

In case of overdosage, discontinue amoxicillin, treat symptomatically, and institute supportive measures as required. A prospective study of 51 pediatric patients at a poison-control center suggested that overdosages of less than 250 mg/kg of amoxicillin are not associated with significant clinical symptoms. Interstitial nephritis resulting in oliguric renal failure has been reported in a small number of patients after overdosage with amoxicillin 1 . Crystalluria, in some cases leading to renal failure, has also been reported after amoxicillin overdosage in adult and pediatric patients. …

If you miss a dose

Take it when you remember, unless it is nearly time for the next dose. Then skip the missed one. Never take two doses at once to make up for it. Check your leaflet, as some medicines are different.

From the official U.S. FDA label for this active ingredient. Your pack may have a different strength, so always read its leaflet. If a doctor prescribed it, follow the prescription. Ask a pharmacist if you are unsure. Label dated 2023-12-18.

Label for amoxicillin (amoxicillin trihydrate) and clavulanic acid (potassium clavulanate), the active ingredient registered with NAFDAC.

Check your pack of Taxoclav 228.8 Powder For Oral Suspension

Add the expiry date on your pack for a full Trust Score.

3 free checks left today Official sources: NAFDAC · WHO · U.S. FDA · Health Canada · NLM

About Taxoclav 228.8 Powder For Oral Suspension

What is in Taxoclav 228.8 Powder For Oral Suspension?

Taxoclav 228.8 Powder For Oral Suspension contains Amoxicillin (Amoxicillin Trihydrate); Clavulanic Acid (Potassium Clavulanate) (200 mg; 28.5 mg), as powder for suspension, according to its NAFDAC registration record.

Is Taxoclav 228.8 Powder For Oral Suspension registered with NAFDAC?

Yes. Taxoclav 228.8 Powder For Oral Suspension is listed on the NAFDAC register under registration number B4-0493, and its registration is active as of 28 October 2026.

Has Taxoclav 228.8 Powder For Oral Suspension been flagged as fake or recalled?

No WHO falsified or substandard medical product alert currently matches Taxoclav 228.8 Powder For Oral Suspension in our automatically synced alert list.

How can I check that my pack of Taxoclav 228.8 Powder For Oral Suspension is genuine?

Run a free authenticity scan with the NAFDAC number B4-0493, your pack's expiry date and batch number to get a Trust Score, compare the pack with the NAFDAC record (ingredient, strength, form, manufacturer), and buy only from licensed pharmacies.

How do I take Taxoclav 228.8 Powder For Oral Suspension?

Follow your prescription or the leaflet in your pack. The official label says: In Adults, 750 to 1750 mg/day in divided doses every 8 to 12 hours. In Pediatric Patients over 3 Months of Age, 20 to 45 mg/kg/day in divided doses every 8 to 12 hours. Refer to full prescribing information for specific dosing regimens. ( 2.2 , 2.3 ) The upper dose for neonates and infants aged 3 months or younger is 30 mg/kg/day divided every 12 hours. ( 2.3 ) Dosing for H. py…

What is Taxoclav 228.8 Powder For Oral Suspension used for?

Adults and Pediatric Patients Upper Respiratory Tract Infections of the Ear, Nose, and Throat: Amoxicillin tablets are indicated in the treatment of infections due to susceptible (ONLY β-lactamase-negative) isolates of Streptococcus species. (α- and β-hemolytic isolates only), Streptococcus pneumoniae , Staphylococcus spp., or Haemophilus influenzae . Infections of the Genitourinary Tract: Amoxici (Summarised from the official U.S. FDA label for amoxicillin (amoxicillin trihydrate) and clavulanic acid (potassium clavulanate). Always follow your doctor or pharmacist.)

Patient reviews

–No reviews yet
5★
0
4★
0
3★
0
2★
0
1★
0
Have you used Taxoclav 228.8 Powder For Oral Suspension? Share your experience to help other patients. Sign in to review

Reviews are personal experiences from PillVera users, not medical advice. Report side effects to your doctor and to NAFDAC.